ENTITY
Zylox-Tonbridge Medical Technology

Zylox-Tonbridge Medical Technology (2190 HK)

43
Analysis
Health CareChina
Leading player in the neuro- and peripheral-vascular interventional medical device market in China.
more
Refresh
22 Jun 2021 23:05

Zylox-Tonbridge IPO: Living On

Zylox-Tonbridge has launched an HKEx IPO to raise net proceeds of $300 million at the mid-point of the IPO price range. Overall, we believe that...

Logo
408 Views
Share
22 Jun 2021 15:30

Zylox-Tonbridge (归创通桥) IPO: Clear Upside Thanks to Comprehensive Coverage

With its comprehensive product coverage in the neuro- and peripheral interventional device segment, we think there's a clear valuation upside for...

Logo
307 Views
Share
20 Jun 2021 09:57

ECM Weekly (20th June 2021) - Didi, Nayuki, Soulgate, Hutchmed, Full Truck, CTOS, Cloud Village

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Share
15 Jun 2021 15:50

Zylox-Tonbridge (归创通桥) Pre-IPO: Competition Is the Key Concern

Zylox-Tonbridge is a leading neuro- and peripheral vascular interventional device company with a comprehensive product coverage. It has two main...

Logo
327 Views
Share
27 Apr 2021 07:29

Pre-IPO Zylox-Tonbridge Medical Technology - Promising Market with Challenges

This insights analyzed Zylox-Tonbridge Medical Technology in terms of the market potential, industry characteristics, business analysis, financial...

Logo
377 Views
Share
x